CLB
Core Laboratories Inc. Energy - Oil & Gas Equipment & Services Investor Relations →
Core Laboratories Inc. (CLB) closed at $14.07 as of 2026-05-01, trading 22.2% below its 200-week moving average of $18.07. This places CLB in the extreme value zone. The stock is currently moving closer to the line, down from -3.6% last week. With a 14-week RSI of 27, CLB is in oversold territory.
A big spike in selling this week — 2.2x the usual volume, and the price dropped. Sometimes this kind of heavy selling marks the end of a decline. The idea is that the last reluctant holders have finally sold, leaving fewer sellers left to push the price lower.
Over the past 1549 weeks of data, CLB has crossed below its 200-week moving average 10 times. On average, these episodes lasted 73 weeks. The average one-year return after crossing below was -0.3%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $648 million, CLB is a small-cap stock. The company generates a free cash flow yield of 7.1%, which is healthy. Return on equity stands at 11.1%. The stock trades at 2.4x book value.
This stock also meets the Yartseva multibagger criteria as a small-cap with strong free cash flow yield and reasonable book value.
Over the past 29.8 years, a hypothetical investment of $100 in CLB would have grown to $497, compared to $1839 for the S&P 500. CLB has returned 5.5% annualized vs 10.3% for the index, underperforming the broader market over this period.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: CLB vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After CLB Crosses Below the Line?
Each line shows $100 invested at the moment CLB crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
CLB has crossed below its 200-week MA 10 times with an average 1-year return of +-0.3% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Mar 2001 | Apr 2001 | 4 | 9.5% | -21.4% | +85.4% |
| Jun 2001 | Dec 2003 | 130 | 54.2% | -40.3% | +66.5% |
| Jan 2004 | Feb 2004 | 3 | 3.1% | +42.8% | +119.4% |
| Oct 2008 | Apr 2009 | 28 | 33.0% | +51.6% | -50.8% |
| Jun 2009 | Jul 2009 | 2 | 6.2% | +80.1% | -58.5% |
| Oct 2014 | Oct 2014 | 1 | 2.3% | -10.6% | -87.5% |
| Nov 2014 | Jan 2018 | 162 | 30.4% | -8.0% | -87.5% |
| Jan 2018 | Apr 2018 | 10 | 7.4% | -39.4% | -86.7% |
| Oct 2018 | Jan 2026 | 378 | 90.0% | -57.5% | -86.0% |
| Feb 2026 | Ongoing | 13+ | 22.2% | Ongoing | -24.2% |
| Average | 73 | — | +-0.3% | — |
Frequently Asked Questions
Is CLB below its 200-week moving average?
Yes. As of 2026-05-01, Core Laboratories Inc. (CLB) is trading 22.2% below its 200-week moving average of $18.07. The current price is $14.07.
What is CLB's 200-week moving average price?
Core Laboratories Inc.'s 200-week moving average is $18.07 as of 2026-05-01. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when CLB drops below its 200-week moving average?
CLB has crossed below its 200-week moving average 10 times in our data. The average one-year return after these crossings was -0.3%, meaning the dips were not reliable buying signals for this particular stock. These episodes lasted 73 weeks on average.
Is CLB a good value right now?
Here's what our data says about CLB as of 2026-05-01: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 27 (oversold). Free cash flow yield is 7.1%. Return on equity is 11.1%. Price-to-book is 2.4x. This is not a buy or sell recommendation — always do your own research.
How does CLB compare to the S&P 500?
Over the past 29.8 years, $100 invested in CLB would have grown to $497, compared to $1839 for the S&P 500. That's 5.5% annualized vs 10.3% for the index. CLB has underperformed the broader market over this period.
Does CLB pay a dividend?
Yes. Core Laboratories Inc. currently pays a dividend yield of 28.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-05-01